Search results
A Novel Broad-Spectrum Antiviral with Activity Against RSV
Digital Journal· 6 days ago(NYSE Amer.:NNVC) (the "Company"), a global leader in broad-spectrum antiviral nanomedicines, says that antiviral activity of NV-387 against RSV/A2 is strong enough to have ...
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 6 days agoProgression-free survival is how long patients live before their cancer worsens. The company added...
Immunotherapy may boost survival after lung cancer surgery
UPI· 4 days agoImmunotherapy can boost the survival of early-stage lung cancer patients eligible for surgery when...
Most cancer treatments are useless for patients with advanced tumors near end of life
UPI· 3 days agoChemotherapies, immunotherapies, targeted therapies and hormone therapies do not improve survival...
US FDA approves Amgen drug for small cell lung cancer
Reuters via AOL· 4 days agoThe U.S. Food and Drug Administration on Thursday granted accelerated approval to Amgen's...
Square: Restaurant Worker Pay Jumps 66% in 7 Years
PYMNTS.com· 6 days agoLabor costs continue to weigh on restaurants, according to a new report by Square. The point-of-sale payments company’s Quarterly Restaurant Report,...
Social media use linked to higher risk of vaping, smoking
UPI· 3 days agoJust 2% of people who reported no social media use engaged in cigarette smoking, but that rose to...
Madagascar's ancient baobab forests are being restored by communities—with a little help from AI
Phys.org· 7 days agoTropical ecologist Seheno Andriantsaralaza has been researching the seed dispersal of baobab trees in Madagascar since 2009. Why are baobab trees so important in Madagascar? Baobab trees are ...
DURECT Corporation Reports First Quarter 2024 Financial Results and Business Update
WRBL Columbus· 7 days agoDURECT Corporation (Nasdaq: DRRX) today announced financial results for the three months ended March 31, 2024 and provided a business update. "We are pleased that the feedback from the U.S.
Earnings call: Bio-Path Holdings reports promising Q1 2024 results
Investing.com· 5 days agoBio-Path Holdings (NASDAQ: NASDAQ: BPTH ), a biotechnology company focused on developing therapeutic...